Researchers developed an antibody-drug conjugate (green) that precisely targets fusion-driven cancers (blue). Source: Sorensen Lab
Credit
Sorensen Lab
Usage Restrictions
none
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.